Occurrence of selected pharmaceutical and non-pharmaceutical compounds, and stable hydrogen and oxygen isotope ratios in a riverbank filtration study, Platte River, Nebraska, 2002 to 2005, Volume 2

This document is the second volume of a data series report that describes the data collected during a study conducted during 2001 through 2005 by the U.S. Geological Survey, in cooperation with the U.S. Environmental Protection Agency and the City of Lincoln, at an established riverbank-filtration well field with horizontal collector wells and vertical wells. The data were collected as part of a study designed to help researchers better understand the efficiency of riverbank filtration with respect to endocrine disrupting compounds and to evaluate the use of riverbank filtration as an effective means of drinking-water treatment. This study provides information that will be useful for (1) increased understanding of the processes and factors controlling the transport of endocrine disrupters, such as pesticides and pharmaceuticals during riverbank filtration, (2) better understanding of the physical and chemical processes that affect riverbank-filtration efficiency, and (3) managing the water resources of the eastern Platte River Basin. This report presents analytical methods and additional data for pharmaceuticals, dissolved organic carbon (DOC), ultraviolet absorbance at 254 nanometer (nm) wavelength (UV254), specific ultraviolet absorbance (SUVA), nitrilotriacetic acid (NTA), ethylenediaminetetraacetic acid (EDTA), nonylphenol ethoxycarboxylates (NPECs), and stable hydrogen and oxygen isotope ratios that were not available at the time of publication of Volume 1 in the data series. Data are presented as generalized statistics and in figures showing temporal variations.

Sites from which water-quality samples were collected for this study included wastewater sites (a cattle feedlot lagoon, a hog confinement lagoon, and wastewater-treatment plant effluent), surface-water sites (Platte River, Salt Creek, and Loup Power Canal), ground-water sites (one collector well and five vertical wells), and drinking-water sites (raw and finished). Field water-quality properties also were measured in samples from these sites.

Pharmaceuticals detected at least once in samples collected from the Platte River included 1,7-dimethylxanthine, acetaminophen, caffeine, carbamazapine, and cotinine. Among the ground-water samples, pharmaceutical compounds detected at low concentrations in at least one sample included 1,7-dimethylxanthine, acetaminophen, carbamazapine, and trimethoprim.

When analyzing for non-pharmaceutical compounds in samples from the wastewater sites, the wastewater-treatment plant effluent samples had the highest concentrations of each of NTA, EDTA, and NPECs compounds. Surface-water samples from Salt Creek had higher concentrations of EDTA and NPECs than samples from the Platte River. NTA was not detected in any samples from the ground-water sites. EDTA was detected in all samples from all wells. Detectable concentrations of EDTA were also observed in all samples from the raw water and finished water.